☆ 4.8 Article

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

LANCET (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients

Stuart L. Cohen et al.

Summary: This study aimed to identify the prevalence and predictors of venous thromboembolism (VTE) or mortality in hospitalized COVID-19 patients. The overall in-hospital VTE rate was 2.9% (4.9% in the ICU) and a VTE or mortality rate of 26.1%. Key predictors of VTE or mortality included advanced age, increasing CCI, history of cardiovascular disease, ICU level of care, and elevated maximum D-dimer with a cutoff at least four times the ULN. Use of prophylactic-dose anticoagulation but not treatment-dose anticoagulation was associated with reduced VTE or mortality.

THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

Gary E. Raskob et al.

Summary: The study found a significant association between asymptomatic proximal deep vein thrombosis (DVT) and all-cause mortality, with a higher mortality rate compared to patients without VTE, similar to symptomatic VTE. This suggests that asymptomatic proximal DVT remains an important endpoint in evaluating the efficacy of anticoagulant thromboprophylaxis in medical patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial

Eduardo Ramacciotti et al.

Summary: The study aims to evaluate the safety and efficacy of rivaroxaban in COVID-19 patients at increased risk for VTE who received standard prophylactic treatment, as well as the role of extended thromboprophylaxis. The results are expected to guide medical decisions in clinical practice.

AMERICAN HEART JOURNAL (2021)

添加到收藏夹

Article Hematology

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

Dimitrios Giannis et al.

Summary: Thromboembolic events and mortality from subclinical thrombotic events frequently occur in COVID-19 inpatients. Postdischarge VTE, ATE, and ACM are common, with advanced age and cardiovascular risk factors increasing the risk. Postdischarge anticoagulation can significantly reduce the risk by 46%.

BLOOD (2021)

添加到收藏夹

Article Medicine, General & Internal

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Renato D. Lopes et al.

Summary: In hospitalized COVID-19 patients with elevated D-dimer concentration, in-hospital therapeutic anticoagulation with rivaroxaban or enoxaparin followed by rivaroxaban to day 30 did not improve clinical outcomes and increased bleeding compared with prophylactic anticoagulation. Therapeutic-dose rivaroxaban and other direct oral anticoagulants should be avoided in these patients without an evidence-based indication for oral anticoagulation.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Julie Helms et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Article Hematology

Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19

Alex C. Spyropoulos et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Critical Care Medicine

Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019 CHEST Guideline and Expert Panel Report

Lisa K. Moores et al.

CHEST (2020)

添加到收藏夹

Article Hematology

Postdischarge venous thromboembolism following hospital admission with COVID-19

Lara N. Roberts et al.

BLOOD (2020)

添加到收藏夹

Article Hematology

Postdischarge thrombosis and hemorrhage in patients with COVID-19

Rushad Patell et al.

BLOOD (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

Alex C. Spyropoulos et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Review Hematology

Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration

Tobias Tritschler et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Hematology

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

Grigoris T. Gerotziafas et al.

THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Meeting Abstract Hematology

Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry

Dimitrios Giannis et al.

BLOOD (2020)

添加到收藏夹

Article Medicine, General & Internal

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Alex C. Spyropoulos et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

Alexander T. Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Hematology

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

S. Kaatz et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

添加到收藏夹

Letter Medicine, General & Internal

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients REPLY

Alexander T. Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Medicine, General & Internal

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

Alexander T. Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Medicine, General & Internal

Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

Samuel Z. Goldhaber et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Medicine, General & Internal

Extended-Duration Venous Thromboembolism Prophylaxis in Acutely III Medical Patients With Recently Reduced Mobility

Russell D. Hull et al.

ANNALS OF INTERNAL MEDICINE (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.